[
  {
    "ts": null,
    "headline": "Viatris Inc. stock falls Monday, underperforms market",
    "summary": "Viatris Inc. stock falls Monday, underperforms market",
    "url": "https://finnhub.io/api/news?id=3413733a6fdc6f02af4e8404c5f41a5d0ceedf28f6ea0315b755c0f1cbc6ef17",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748884680,
      "headline": "Viatris Inc. stock falls Monday, underperforms market",
      "id": 135032270,
      "image": "",
      "related": "VTRS",
      "source": "MarketWatch",
      "summary": "Viatris Inc. stock falls Monday, underperforms market",
      "url": "https://finnhub.io/api/news?id=3413733a6fdc6f02af4e8404c5f41a5d0ceedf28f6ea0315b755c0f1cbc6ef17"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
    "summary": "LOS ANGELES, June 2, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Viatris Inc. . ...",
    "url": "https://finnhub.io/api/news?id=6bd0ed45165682240b6470a68aa325acd0567ce4dc960bbf32e0f2d5aeed9648",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748865668,
      "headline": "Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
      "id": 134945513,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "LOS ANGELES, June 2, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Viatris Inc. . ...",
      "url": "https://finnhub.io/api/news?id=6bd0ed45165682240b6470a68aa325acd0567ce4dc960bbf32e0f2d5aeed9648"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions",
    "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from LYNX-2, a pivotal Phase 3 trial evaluating MR-142 (phentolamine ophthalmic solution 0.75%) in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision. This study was conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (U.S. FDA).",
    "url": "https://finnhub.io/api/news?id=e89b104c467f778a196dc8abb623bebfc6e0eefbbf77ac43dd9fbf395bfdd3c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748865600,
      "headline": "Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions",
      "id": 134937578,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from LYNX-2, a pivotal Phase 3 trial evaluating MR-142 (phentolamine ophthalmic solution 0.75%) in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision. This study was conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (U.S. FDA).",
      "url": "https://finnhub.io/api/news?id=e89b104c467f778a196dc8abb623bebfc6e0eefbbf77ac43dd9fbf395bfdd3c8"
    }
  },
  {
    "ts": null,
    "headline": "VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. for violations of...",
    "url": "https://finnhub.io/api/news?id=6d41cd97eb874801077f56802b7b056a1b0744b739613c29eed8eb2ec7cca57a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748856726,
      "headline": "VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 134938798,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "LOS ANGELES, June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. for violations of...",
      "url": "https://finnhub.io/api/news?id=6d41cd97eb874801077f56802b7b056a1b0744b739613c29eed8eb2ec7cca57a"
    }
  },
  {
    "ts": null,
    "headline": "DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ",
    "summary": "PHILADELPHIA, June 2, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. on behalf of purchasers of...",
    "url": "https://finnhub.io/api/news?id=dec298943af26e0518cf81563eb1cf6c0dd0abc440b5cebeb8d0f4a4bb214549",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748855345,
      "headline": "DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ",
      "id": 134938233,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "PHILADELPHIA, June 2, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. on behalf of purchasers of...",
      "url": "https://finnhub.io/api/news?id=dec298943af26e0518cf81563eb1cf6c0dd0abc440b5cebeb8d0f4a4bb214549"
    }
  }
]